3m's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is 3m's ROA in the third quarter of 2026?
3m Company achieved a return on average assets (ROA) of 8.06 % in its third quarter of 2026, which is below 3m's average return on assets, which stands at 12.15%.

ROA has improved compared to 7.57% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 97 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 835, from total ROA ranking in the second quarter of 2026 at 845.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	45.14 %	30.99 %	-9.98 %	-4.13 %	-7.93 %
Y / Y Net Income Change	63.26 %	29.38 %	-41.27 %	-21.15 %	-38.88 %
Net Income (TTM) in million	3,544	3,012	2,799	3,262	3,416
Return On Assets (TTM)	8.06 %	7.57 %	7.58 %	8.61 %	8.92 %
MMM's Total Ranking	# 835	# 845	# 703	# 622	# 561
Total Assets (TTM) in million	53,809	49,012	35,436	37,733	37,074
Seq. Total Assets Change	9.79 %	38.31 %	-6.09 %	1.78 %	-0.91 %
Seq. Net Income Change	46.38 %	42.34 %	14.81 %	-31.75 %	16 %

MMM's 5 Years Annual ROA >> Back to MMM Management Effectiveness >> Compare MMM ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 29
Sector	# 98
Overall	# 624

Return On Assets Statistics
High	Average	Low
19.47 %	12.15 %	-15.39 %
(March 31, 2007)		(Sep 30 2023)

Financial Statements
3m's Assets	$ 53,809 million	MMM's Balance sheet
3m's Income	$ 1,373 million	Quarterly MMM's Income Statement
MMM's Income by Division		See MMM's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-3.99 %	-21.11 %	9.19 %	-1.27 %	-0.57 %
Total Assets in million	37,733	39,303	49,821	45,626	46,214
Y / Y Net Income Change	-22.11 %	-	-	-2.33 %	10.04 %
Net Income in million	3,262	4,188	-6,979	5,791	5,929
Annual Return On Assets	8.64 %	10.66 %	-14.01 %	12.69 %	12.83 %

MMM's 5 Years Annual ROA >> Back to MMM Management Effectiveness >> Compare MMM ROA to its Competitors

Comment on MMM's ROA in the fiscal year ending 2025

In the fiscal year 2025 3m's ROA decreased compared to previous year to 8.64 %, due to deterioration of net income -22.11 % to $3,262.00 million, from $4,188.00 million a year ago, as MMM's assets were $37,733.00 million.

More Return On Assets Ratios
MMM's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MMM's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MMM's Competitors
Subscribers only: Roa for 3m's Suppliers
Subscribers only: Return On Assets for MMM's Customers

You may also want to know
MMM's Roi	MMM's Inventory Turnover Ratio	MMM's Growth Rates	MMM's Dividend Comparisons
	MMM's Profitability Ratios	MMM's Asset Turnover Ratio	MMM's Dividend Growth
MMM's Roe	MMM's Valuation Ratios	MMM's Financial Strength Ratios	MMM's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Acadia Pharmaceuticals Inc	21.60 %
Standard Biotools Inc	21.56 %
Eli Lilly And Company	21.24 %
Iradimed Corporation	20.89 %
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %

Date modified: 2026-10-21T05:02:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.